Toggle navigation
Home
Search
Services
Blog
Contact
About
TB Center Grant
Temesgen, Zelalem
Mayo Clinic, Rochester, Rochester, MN, United States
Search 11 grants from Zelalem Temesgen
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanical Regulation of Tumor Angiogenesis
Mechanisms of Polycystin and Cilia Function in ADPKD
Marital Conflict: Intrapersonal & Interpersonal Factors
Coping with Work and Family Stress: Impact on Drug Use
Technical Support for the US Antarctic Program
Recently added grants:
Nuclear pore regulation of leukemia cell metabolism and survival
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism
Characterization of a Novel lncRNA in Breast Cancer
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for HIV, Viral Hepatitis, STDS and Tb Prevention (NCHHSTP)
Type
Cooperative Agreement for Tuberculosis Control (U52)
Project #
1U52PS004096-01
Application #
8536452
Study Section
Special Emphasis Panel (ZPS1-SRC (99))
Project Start
2013-01-01
Project End
2017-12-31
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
1
Fiscal Year
2013
Total Cost
$1,072,947
Indirect Cost
$79,480
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2015
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
NIH 2014
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
$536,474
NIH 2013
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
$1,072,947
Comments
Be the first to comment on Zelalem Temesgen's grant